LivaNova PLC - Asset Resilience Ratio

Latest as of December 2024: 0.00%

LivaNova PLC (LIVN) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check LivaNova PLC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$42.00K
Cash + Short-term Investments

Total Assets

$2.51 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1998–2022)

This chart shows how LivaNova PLC's Asset Resilience Ratio has changed over time. See LivaNova PLC balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down LivaNova PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is LivaNova PLC worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $42.00K 0.0%
Total Liquid Assets $42.00K 0.00%

Asset Resilience Insights

  • Limited Liquidity: LivaNova PLC maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

LivaNova PLC Industry Peers by Asset Resilience Ratio

Compare LivaNova PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic PLC
XETRA:2M6
Medical Devices 7.91%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
Aroa Biosurgery Ltd
AU:ARX
Medical Devices 12.13%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Bluelinea SA
PA:ALBLU
Medical Devices 1.07%
elexxion AG
XETRA:E8X
Medical Devices 5.50%

Annual Asset Resilience Ratio for LivaNova PLC (1998–2022)

The table below shows the annual Asset Resilience Ratio data for LivaNova PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.00% $-34.00K $2.29 Billion 0.00pp
2021-12-31 0.00% $-2.00K $2.20 Billion -1.30pp
2020-12-31 1.30% $31.09 Million $2.40 Billion +1.19pp
2018-12-31 0.10% $2.65 Million $2.55 Billion -0.01pp
2017-12-31 0.12% $2.94 Million $2.50 Billion +0.12pp
2016-12-31 0.00% $-8.00K $2.34 Billion -0.27pp
2015-12-31 0.27% $7.00 Million $2.56 Billion -8.23pp
2014-12-31 8.51% $25.03 Million $294.19 Million 0.00pp
2013-12-31 8.51% $25.03 Million $294.19 Million +2.79pp
2012-12-31 5.72% $15.10 Million $264.04 Million -1.36pp
2011-12-31 7.08% $15.00 Million $211.91 Million +6.60pp
2009-12-31 0.48% $1.00 Million $207.47 Million -0.20pp
2008-12-31 0.68% $1.00 Million $146.21 Million -0.27pp
2007-12-31 0.95% $1.00 Million $105.19 Million +0.22pp
2006-12-31 0.73% $1.00 Million $136.23 Million +0.08pp
2005-12-31 0.66% $1.00 Million $152.30 Million -22.41pp
2004-12-31 23.06% $22.80 Million $98.86 Million +22.98pp
2000-12-31 0.08% $57.54K $67.99 Million -3.80pp
1999-12-31 3.89% $1.56 Million $40.00 Million -44.35pp
1998-12-31 48.24% $19.20 Million $39.80 Million --
pp = percentage points

About LivaNova PLC

NASDAQ:LIVN USA Medical Devices
Market Cap
$4.58 Billion
Market Cap Rank
#4250 Global
#1452 in USA
Share Price
$83.43
Change (1 day)
+2.94%
52-Week Range
$41.13 - $83.43
All Time High
$130.95
About

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. … Read more